Regeneron Pharmaceuticals, Inc. (REGN)

751.91 +4.55 (+0.61%) USD  |  NASDAQ  |  Apr 22, 10:00
More

Regeneron Pharmaceuticals Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
AbbVie, Inc. Upgrade